In this video, we will look at key considerations for oligo therapeutic developers entering the market, such as scalability, flexibility, regulatory concerns, insource/outsource considerations, and security of supply. You will learn about:
• the oligonucleotide therapeutic market
• the therapeutics in development
• challenges you may face and key considerations to address those challenges
• how to scale up manufacturing